Literature DB >> 21893635

Individualizing glycemic targets in type 2 diabetes mellitus.

David Aron, Paul R Conlin, Curtis Hobbs, Robert A Vigersky, Leonard Pogach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21893635     DOI： 10.7326/0003-4819-155-5-201109060-00025

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.

Authors:  Andrew I Geller; Nadine Shehab; Maribeth C Lovegrove; Scott R Kegler; Kelly N Weidenbach; Gina J Ryan; Daniel S Budnitz
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

2.  Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

Authors:  Sandeep Vijan; Jeremy B Sussman; John S Yudkin; Rodney A Hayward
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

3.  Comparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes.

Authors:  Cheol-Young Park; Jun Goo Kang; Suk Chon; Junghyun Noh; Seung Joon Oh; Chang Beom Lee; Sung Woo Park
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.